Pengaruh Good Corporate Governance dan Kinerja Keuangan Terhadap Harga Saham pada Perusahaan Sektor Farmasi Yang Terdaftar Di Bursa Efek Indonesia (BEI) Periode 2016-2020

Abstract

The pharmaceutical industry is a true alternative for investors in investing their capital with a fairly low risk estimate to get a profit, this is supported by a very fast progressive era, the business of medical equipment, drugs, and many hospitals are progressing rapidly. The importance of stock prices can be used to measure the value of the company and its performance, and even stock prices are used to reflect investor confidence. The highs and lows of stock prices can be seen from the company's governance and also its financial performance. This study aims to determine the effect of good corporate governance and financial performance on stock prices. The type of research that will be conducted is explanatory with a quantitative approach, namely to analyze and explain why or how the phenomenon under study occurs. The results of this study indicate that the variables of the board of directors, the board of commissioners, the audit committee, independent commissioners and institutional ownership have no significant effect on stock prices, the debt to equity ratio (DER) variable has a positive and significant effect on stock prices, the return on equity (ROE) variable positive and significant effect on stock prices.